12/16/2008

Abbott Laboratories secured FDA clearance to market TriLipix, a cholesterol drug that can be used alone or with statins to manage lipid problems. TriLipix contains the active ingredient in the firm's TriCor, a blockbuster cholesterol medication that will start losing patent protection in 2011.

Related Summaries